Bob Li, SVP World Head of Medical Affairs of Oncology at AstraZeneca, shared on LinkedIn:
“I’m extremely proud to work for AstraZeneca, an organization that persistently prioritizes strategic partnerships and worldwide collaboration to make an actual distinction.
Not too long ago, AZ has introduced a big funding in a groundbreaking initiative – the primary for the Pan-American Cancer Consortium (PACC), led by the Bloomberg New Financial system Worldwide Most cancers Coalition.
This highly effective collaboration will considerably broaden entry to most cancers scientific trials for sufferers in Brazil’s public well being system SUS, immediately addressing important care gaps via shared experience and innovation.
PACC’s inaugural two-year pilot in Brazil, in partnership with Hospital Sírio-Libanês, in Sao Paulo, and Memorial Sloan Kettering Most cancers Heart (MSK), will combine superior molecular testing and AI-powered trial matching into 5 public oncology hospitals. This can dramatically broaden entry to over 200 most cancers scientific trials, enhancing analysis variety and strengthening precision oncology for underserved sufferers.
This formidable initiative demonstrates what we are able to obtain once we unite throughout borders, leverage cutting-edge science, and stay relentlessly targeted on international affected person influence.”
Different articles about AstraZeneca on OncoDaily.
